Reaction
Retinal Ischaemia reporting signals
As of the last recalculation, Retinal Ischaemia appears in 591 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 95.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 64 | 95.1 | 95.3 |
| Ganciclovir | 14 | 49.3 | 49.4 |
| Ganciclovir Sodium | 14 | 47.7 | 47.8 |
| Posaconazole Delayed-Release | 14 | 46.0 | 46.0 |
| Aflibercept | 37 | 44.5 | 44.5 |
| Amphotericin B | 15 | 43.2 | 43.3 |
| Faricimab | 8 | 35.2 | 35.3 |
| Moxifloxacin | 13 | 33.2 | 33.2 |
| Moxifloxacin Hydrochloride | 18 | 32.2 | 32.2 |
| Posaconazole | 14 | 31.1 | 31.1 |
| Cefepime | 11 | 27.5 | 27.5 |
| Melphalan Hydrochloride | 18 | 26.0 | 26.1 |
| Voriconazole Injection | 15 | 24.9 | 25.0 |
| Cefepime Hydrochloride | 11 | 24.5 | 24.5 |
| Dextrose | 9 | 24.4 | 24.4 |
| Dextrose Monohydrate | 9 | 24.1 | 24.1 |
| Norepinephrine | 7 | 23.3 | 23.3 |
| Amikacin | 11 | 23.1 | 23.1 |
| Norepinephrine Bitartrate | 9 | 22.3 | 22.4 |
| Voriconazole | 17 | 20.3 | 20.3 |
| Bleomycin Sulfate | 5 | 17.2 | 17.2 |